Fagron NV (EBR:FAGR)
Belgium · Delayed Price · Currency is EUR 22.70
0.00 (0.00%)
At close: Jan 20, 2026
Fagron NV Market Cap
Fagron NV has a market cap or net worth of €1.66 billion as of January 20, 2026. Its market cap has increased by 35.10% in one year.
Market Cap
1.66B
Enterprise Value
1.98B
Revenue
918.75M
Ranking
n/a
PE Ratio
19.40
Stock Price
€22.70
Market Cap Chart
Since October 15, 2007, Fagron NV's market cap has increased from 312.17M to 1.66B, an increase of 432.60%. That is a compound annual growth rate of 9.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 1.66B | 6.57% |
| Dec 31, 2025 | 1.56B | 27.67% |
| Dec 31, 2024 | 1.22B | 0.73% |
| Dec 29, 2023 | 1.21B | 25.41% |
| Dec 30, 2022 | 967.24M | -10.30% |
| Dec 31, 2021 | 1.08B | -21.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 50.46B |
| argenx SE | 42.45B |
| Financière de Tubize | 10.48B |
| Ion Beam Applications | 410.90M |
| Hyloris Pharmaceuticals | 221.20M |
| Onward Medical | 202.43M |
| Nyxoah | 186.95M |
| Sequana Medical NV | 32.32M |